Trademark Overview
On Wednesday, November 12, 2025, a trademark application was filed for REVALIQ with the United States Patent and Trademark Office. The USPTO has given the REVALIQ trademark a serial number of 99493250. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, March 23, 2026. This trademark is owned by Tranzformiq Health, LLC. The REVALIQ trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:
Business consulting and information services; Business consulting services in the field of the healthcare industry, namely, the collection, reporting, and analysis of healthcare quality data for business purposes; Business consulting services in the field of healthcare, finance, and contract negotiations
Software as a service (SAAS) services featuring software using artificial intelligence (AI) for use in database management, business analytics, and data integration; Providing on-line non-downloadable software for use in contract management, financial analysis, and business decision-making; Providing temporary use of on-line non-downloadable software for managing, analyzing, and reporting healthcare, business, and financial data
